Latest News & Features
Americas
The US Patent and Trademark Office has granted ERS Genomics its first US patent covering the use of CRISPR/Cas9 technology for gene editing. 20 June 2018
Americas
Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts. 20 June 2018
Asia
Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China. 20 June 2018
Americas
The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics. 19 June 2018
Biotechnology
Germany-based drug discovery company Evotec has signed a deal to acquire most of Sanofi’s infectious disease unit. 19 June 2018
Americas
Addiction treatment drug producer Indivior has obtained a temporary restraining order against Indian generic maker Dr Reddy’s, blocking the company from launching a generic version of Suboxone (buprenorphine and naloxone) Film. 18 June 2018
Americas
US Senator Orrin Hatch has proposed an amendment to the Hatch-Waxman Act to “restore the careful balance” the act struck to incentivise generic drug development. 15 June 2018
Asia
US-based biopharmaceutical company Sage Therapeutics and Japan-based pharmaceutical corporation Shionogi have entered into a strategic collaboration to develop an antidepressant drug. 15 June 2018
Americas
The Patent Trial and Appeal Board has now rejected challenges to six patents owned by Gilead covering the company’s hepatitis C medicines. 14 June 2018
Big Pharma
The EU General Court today ruled on a pharmaceutical trademark dispute over the names ‘Emcur’ and ‘Emcure’, finding similarity for some goods and services but not others. 14 June 2018